Ryan Martins - 31 Mar 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Financial Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Issuer symbol
ETNB
Transactions as of
31 Mar 2023
Net transactions value
-$70,241
Form type
4
Filing time
04 Apr 2023, 16:20:49 UTC
Previous filing
27 Mar 2023
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +5,833 +11% $0.000000 59,411 31 Mar 2023 Direct F1
transaction ETNB Common Stock Tax liability $30,734 -2,018 -3.4% $15.23 57,393 31 Mar 2023 Direct F2
transaction ETNB Common Stock Award $0 +7,500 +13% $0.000000 64,893 31 Mar 2023 Direct F3
transaction ETNB Common Stock Tax liability $39,507 -2,594 -4% $15.23 62,299 31 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan (the "Plan") on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
F3 Represents settlement by the Issuer of performance-based RSUs granted to the Reporting Person under the Plan on February 17, 2022, which vested based on the Issuer's achievement of department performance objectives.